FAM
PCVX icon

Fred Alger Management’s Vaxcyte PCVX Stock Holding History

Fred Alger Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.8M Sell
116,965
-153,150
-57% -$8.32M 0.02% 211
2026
Q1 		$15.7M Buy
270,115
+212,307
+367% +$11.5M 0.07% 127
2025
Q4 		$2.67M Buy
57,808
+12,394
+27% +$554K 0.01% 296
2025
Q3 		$1.64M Buy
45,414
+27,143
+149% +$899K 0.01% 335
2025
Q2 		$594K Sell
18,271
-4,089
-18% -$134K ﹤0.01% 380
2025
Q1 		$844K Sell
22,360
-500,647
-96% -$40M ﹤0.01% 336
2024
Q4 		$42.8M Sell
523,007
-720,710
-58% -$71.6M 0.2% 77
2024
Q3 		$142M Sell
1,243,717
-66,719
-5% -$6.01M 0.69% 30
2024
Q2 		$99M Sell
1,310,436
-86,275
-6% -$5.87M 0.48% 45
2024
Q1 		$95.4M Sell
1,396,711
-273,478
-16% -$18.9M 0.47% 44
2023
Q4 		$105M Sell
1,670,189
-423,116
-20% -$22M 0.57% 44
2023
Q3 		$107M Sell
2,093,305
-277,913
-12% -$13.7M 0.61% 38
2023
Q2 		$118M Buy
2,371,218
+1,526,440
+181% +$72.4M 0.6% 37
2023
Q1 		$31.7M Sell
844,778
-32,515
-4% -$1.38M 0.17% 137
2022
Q4 		$42.1M Buy
+877,293
New +$34.4M 0.23% 127
2022
Q2 		– Sell
-9,677
Closed -$234K – 538
2022
Q1 		$234K Buy
+9,677
New +$211K ﹤0.01% 434

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Fred Alger Management's PCVX Position: Q2 2026 in Review

Fred Alger Management reduced its Vaxcyte (PCVX) stake by 57% in Q2 2026, selling an estimated $8.32M and leaving 116,965 shares worth $6.8M. The position accounts for 0.02% of the portfolio, ranked #211.

Fred Alger Management first reported a position in PCVX in Q1 2022 and has held it in 16 quarters since. The position peaked at $142M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Fred Alger Management held 116,965 shares of Vaxcyte worth $6.8M as of Q2 2026.
  • Fred Alger Management sold 153,150 Vaxcyte shares in Q2 2026, an estimated $8.32M.
  • Vaxcyte made up 0.02% of Fred Alger Management's portfolio in Q2 2026, its #211 holding.
  • Fred Alger Management first reported a position in Vaxcyte in Q1 2022 and has held it in 16 quarters since.
  • Fred Alger Management's Vaxcyte position peaked at $142M in Q3 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.